Efficacy of second line chemotherapy following first line triplet chemotherapy in advanced colorectal cancer (ACRC)

被引：0
|
作者：
Hakoun, A. M. [1 ]
Gad, A. M. [2 ]
Alzahrani, A. [3 ]
Aljubran, A. [3 ]
Bazarbashi, S. [3 ]
机构：
[1] Alfaisal Univ, Coll Med, Res Off Dept, Riyadh, Saudi Arabia
[2] Ain Shams Univ, Fac Med, Dept Clin Oncol, Cairo, Egypt
[3] King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh, Saudi Arabia
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer
    Bazarbashi, S.
    Hakoun, A. M.
    Gad, A. M.
    Elshenawy, M. A.
    Aljubran, A.
    Alzahrani, A. M.
    Eldali, A.
    CURRENT ONCOLOGY, 2019, 26 (01) : E24 - E29
  • [2] Is there a second line chemotherapy in colorectal cancer?
    Schmoll, HJ
    EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY - 21ST ESMO CONGRESS, EDUCATIONAL BOOK, 1996, : 35 - 42
  • [3] Capecitabine and irinotecan as first line therapy in advanced colorectal cancer (ACRC)
    Laudani, A.
    Savio, G.
    Leonardi, V.
    Usset, A.
    Pepe, A.
    Calabria, C.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2005, 16 : 43 - 43
  • [4] The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer
    Naito, Renato
    Izumi, Kouji
    Kadomoto, Suguru
    Makino, Tomoyuki
    Iwamoto, Hiroaki
    Yaegashi, Hiroshi
    Shigehara, Kazuyoshi
    Kadono, Yoshifumi
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2020, 40 (02) : 1141 - 1146
  • [5] TITULO: RESULTS OF BEVACIZUMAB IN COMBINATION WITH FIRST LINE AND SECOND LINE CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER
    Castano, A.
    Aristizabal, N.
    ANNALS OF ONCOLOGY, 2009, 20 : 78 - 78
  • [6] Mayo regimen plus three different second-line chemotherapy regimens in sequential therapy in patients with Advanced Colorectal Cancer (ACRC)
    Popov, IP
    Jelic, SB
    Matijasevic, MM
    Grbic, B
    Babic, DR
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (03) : 395 - 401
  • [7] Second-Line Chemotherapy of Advanced Colorectal Cancer: Predictive and Prognostic Factors
    Forgacz, Krzysztof
    Agrawal, Anil K.
    Sawicki, Tomasz
    Marek, Grzegorz W.
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (04): : 725 - 732
  • [8] First line chemotherapy of advanced ovarian cancer
    du Bois, A
    MEDIZINISCHE WELT, 2001, 52 (03): : 53 - +
  • [9] Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer
    Hoba, Julien
    Grancher, Adrien
    Hautefeuille, Vincent
    Turpin, Anthony
    Bouhier-Leporrier, Karine
    Galais, Marie-Pierre
    Bignon, Anne-Laure
    Di Fiore, Aude
    Desgrippes, Romain
    Miglianico, Laurent
    Avisse, Benoit
    Baconnier, Mathieu
    Lam, You-Heng
    Dutherage, Marie
    Sefrioui, David
    Le Malicot, Karine
    Phelip, Jean-Marc
    Michel, Pierre
    Gillibert, Andre
    Di Fiore, Frederic
    DIGESTIVE AND LIVER DISEASE, 2025, 57 (01) : 30 - 37
  • [10] When to Use Triplet Chemotherapy as First-Line Treatment in Metastatic Colorectal Cancer
    Cremolini, Chiara
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 433 - 435
12345